Literature DB >> 34593595

Appropriate Use Criteria for Prostate-Specific Membrane Antigen PET Imaging.

Hossein Jadvar1, Jeremie Calais2, Stefano Fanti3, Felix Feng4, Kirsten L Greene5, James L Gulley6, Michael Hofman7, Bridget F Koontz8, Daniel W Lin9, Michael J Morris10, Steve P Rowe11, Trevor J Royce12, Simpa Salami13, Bital Savir-Baruch14, Sandy Srinivas15, Thomas A Hope16.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34593595      PMCID： PMC8717184          DOI： 10.2967/jnumed.121.263262

Source DB:  PubMed          Journal:  J Nucl Med        ISSN： 0161-5505            Impact factor:   11.082


× No keyword cloud information.
  85 in total

Review 1.  Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: the American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel report and recommendations for a standard in the reporting of surgical outcomes.

Authors:  Michael S Cookson; Gunnar Aus; Arthur L Burnett; Edith D Canby-Hagino; Anthony V D'Amico; Roger R Dmochowski; David T Eton; Jeffrey D Forman; S Larry Goldenberg; Javier Hernandez; Celestia S Higano; Stephen R Kraus; Judd W Moul; Catherine Tangen; J Brantley Thrasher; Ian Thompson
Journal:  J Urol       Date:  2007-02       Impact factor: 7.450

2.  Head-to-Head Comparison of 68Ga-PSMA-11 with 18F-PSMA-1007 PET/CT in Staging Prostate Cancer Using Histopathology and Immunohistochemical Analysis as a Reference Standard.

Authors:  Jonathan Kuten; Ibrahim Fahoum; Ziv Savin; Ofer Shamni; Gilad Gitstein; Dov Hershkovitz; Nicola J Mabjeesh; Ofer Yossepowitch; Eyal Mishani; Einat Even-Sapir
Journal:  J Nucl Med       Date:  2019-09-27       Impact factor: 10.057

3.  A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer.

Authors:  M W Kattan; J A Eastham; A M Stapleton; T M Wheeler; P T Scardino
Journal:  J Natl Cancer Inst       Date:  1998-05-20       Impact factor: 13.506

4.  Semiquantitative Parameters in PSMA-Targeted PET Imaging with [18F]DCFPyL: Impact of Tumor Burden on Normal Organ Uptake.

Authors:  Rudolf A Werner; Ralph A Bundschuh; Lena Bundschuh; Constantin Lapa; Yafu Yin; Mehrbod S Javadi; Andreas K Buck; Takahiro Higuchi; Kenneth J Pienta; Martin G Pomper; Martin A Lodge; Michael A Gorin; Steven P Rowe
Journal:  Mol Imaging Biol       Date:  2020-02       Impact factor: 3.488

5.  Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Compared with Conventional Imaging for Initial Staging of Treatment-naïve Intermediate- and High-risk Prostate Cancer: A Retrospective Single-center Study.

Authors:  Andrew T Lenis; Aydin Pooli; Patrick M Lec; Taylor Y Sadun; David C Johnson; Cedric Lebacle; Wolfgang P Fendler; Matthias Eiber; Johannes Czernin; Robert E Reiter; Jeremie Calais
Journal:  Eur Urol Oncol       Date:  2020-09-18

Review 6.  Imaging evaluation of prostate cancer with 18F-fluorodeoxyglucose PET/CT: utility and limitations.

Authors:  Hossein Jadvar
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-02-22       Impact factor: 9.236

7.  Optimum Imaging Strategies for Advanced Prostate Cancer: ASCO Guideline.

Authors:  Edouard J Trabulsi; R Bryan Rumble; Hossein Jadvar; Thomas Hope; Martin Pomper; Baris Turkbey; Andrew B Rosenkrantz; Sadhna Verma; Daniel J Margolis; Adam Froemming; Aytekin Oto; Andrei Purysko; Matthew I Milowsky; Heinz-Peter Schlemmer; Matthias Eiber; Michael J Morris; Peter L Choyke; Anwar Padhani; Jorge Oldan; Stefano Fanti; Suneil Jain; Peter A Pinto; Kirk A Keegan; Christopher R Porter; Jonathan A Coleman; Glenn S Bauman; Ashesh B Jani; Jeffrey M Kamradt; Westley Sholes; H Alberto Vargas
Journal:  J Clin Oncol       Date:  2020-01-15       Impact factor: 44.544

8.  Diagnostic Accuracy of 68Ga-PSMA-11 PET for Pelvic Nodal Metastasis Detection Prior to Radical Prostatectomy and Pelvic Lymph Node Dissection: A Multicenter Prospective Phase 3 Imaging Trial.

Authors:  Thomas A Hope; Matthias Eiber; Wesley R Armstrong; Roxanna Juarez; Vishnu Murthy; Courtney Lawhn-Heath; Spencer C Behr; Li Zhang; Francesco Barbato; Francesco Ceci; Andrea Farolfi; Sarah M Schwarzenböck; Marcus Unterrainer; Helle D Zacho; Hao G Nguyen; Matthew R Cooperberg; Peter R Carroll; Robert E Reiter; Stuart Holden; Ken Herrmann; Shaojun Zhu; Wolfgang P Fendler; Johannes Czernin; Jeremie Calais
Journal:  JAMA Oncol       Date:  2021-11-01       Impact factor: 33.006

9.  Prospective study to define the clinical utility and benefit of Decipher testing in men following prostatectomy.

Authors:  Joseph Marascio; Daniel E Spratt; Jingbin Zhang; Edouard J Trabulsi; Tiffany Le; Worlanyo Sosu Sedzorme; Whitney H Beeler; Elai Davicioni; Bashar Dabbas; Daniel W Lin; John L Gore; Matthew Bloom; Mark Mann; J Ryan Mark; Anne Calvaresi; James L Godwin; Peter McCue; Mark D Hurwitz; W Kevin Kelly; Costas D Lallas; Karen E Knudsen; Leonard G Gomella; Adam P Dicker; Robert B Den
Journal:  Prostate Cancer Prostatic Dis       Date:  2019-11-12       Impact factor: 5.554

10.  A Phase 2/3 Prospective Multicenter Study of the Diagnostic Accuracy of Prostate Specific Membrane Antigen PET/CT with 18F-DCFPyL in Prostate Cancer Patients (OSPREY).

Authors:  Kenneth J Pienta; Michael A Gorin; Steven P Rowe; Peter R Carroll; Frédéric Pouliot; Stephan Probst; Lawrence Saperstein; Mark A Preston; Ajjai S Alva; Akash Patnaik; Jeremy C Durack; Nancy Stambler; Tess Lin; Jessica Jensen; Vivien Wong; Barry A Siegel; Michael J Morris
Journal:  J Urol       Date:  2021-02-26       Impact factor: 7.450
View more
  4 in total

1.  Prostate-specific Membrane Antigen PET: Standard Imaging in Prostate Cancer.

Authors:  Hossein Jadvar
Journal:  Radiology       Date:  2022-05-24       Impact factor: 29.146

Review 2.  Recent Advancements in CT and MR Imaging of Prostate Cancer.

Authors:  Asha Daryanani; Baris Turkbey
Journal:  Semin Nucl Med       Date:  2021-12-18       Impact factor: 4.802

Review 3.  PSMA PET in Imaging Prostate Cancer.

Authors:  Ioannis Tsechelidis; Alexis Vrachimis
Journal:  Front Oncol       Date:  2022-01-28       Impact factor: 6.244

Review 4.  Radiolabeled PSMA Inhibitors.

Authors:  Oliver C Neels; Klaus Kopka; Christos Liolios; Ali Afshar-Oromieh
Journal:  Cancers (Basel)       Date:  2021-12-13       Impact factor: 6.639
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.